JP5741576B2 - 薬物送達医療機器 - Google Patents
薬物送達医療機器 Download PDFInfo
- Publication number
- JP5741576B2 JP5741576B2 JP2012513739A JP2012513739A JP5741576B2 JP 5741576 B2 JP5741576 B2 JP 5741576B2 JP 2012513739 A JP2012513739 A JP 2012513739A JP 2012513739 A JP2012513739 A JP 2012513739A JP 5741576 B2 JP5741576 B2 JP 5741576B2
- Authority
- JP
- Japan
- Prior art keywords
- drug
- drug delivery
- medical device
- nanocarriers
- delivery medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/104—Balloon catheters used for angioplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/0045—Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1027—Making of balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/624—Nanocapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/626—Liposomes, micelles, vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1088—Balloon catheters with special features or adapted for special applications having special surface characteristics depending on material properties or added substances, e.g. for reducing friction
Description
Claims (13)
- 薬物送達医療機器であって、
バルーンカテーテル、および
前記バルーンカテーテルに取り付けられたインフレータブルバルーンを含み、
前記インフレータブルバルーンは親水性表面を有し、前記親水性表面の少なくとも1部分は複数のナノキャリアで被覆されており、複数の前記ナノキャリアのそれぞれは封入剤によって取り囲まれた薬物を含み、前記ナノキャリアの表面には薬物が存在せず、前記インフレータブルバルーンが身体内腔における標的部位に近接して膨張すると、複数の前記ナノキャリアの30%〜80%が15−90秒以内に前記親水性表面から放出され、
複数の前記ナノキャリアは、ナノキャリアの第1セット、ナノキャリアの第2セット、およびナノキャリアの第3セットを含み、前記ナノキャリアの第1セットは、内膜層に存在する細胞間の孔を介した前記内膜層への浸透に適した800nm〜1500nmの範囲の第1平均直径を有し、前記ナノキャリアの第2セットは、中膜層と関連する脈管の血管および前記内膜層に存在する細胞間の孔を介した中膜層への浸透に適した300nm〜800nmの範囲の第2平均直径を有し、前記ナノキャリアの第3セットは、前記内膜層に存在する細胞間の孔、前記中膜層と関連する脈管の血管、および外膜層と関連する脈管の血管を介した前記外膜層への浸透に適した10nm〜300nmの範囲の第3平均直径を有し、
前記封入剤は、生物学的薬剤、リン脂質、および血液添加物の中から選択され、
前記ナノキャリアが前記標的部位内に浸透し、前記封入剤が溶解した後、前記薬物が放出されることを特徴とする薬物送達医療機器。 - 請求項1に記載の薬物送達医療機器であって、前記インフレータブルバルーンは遠位端および近位端を有し、前記インフレータブルバルーンの前記遠位端の少なくとも1部分および前記インフレータブルバルーンの前記近位端の少なくとも1部分は、前記複数のナノキャリアで被覆されていない薬物送達医療機器。
- 請求項1に記載の薬物送達医療機器であって、前記生物学的薬剤および前記リン脂質は、前記標的部位に対する親和性、および前記薬物の安定化を含む群より選択される少なくとも1つの効果を有する薬物送達医療機器。
- 請求項1に記載の薬物送達医療機器であって、前記生物学的薬剤は、7.4未満のpHを有する媒体に溶解する薬物送達医療機器。
- 請求項1に記載の薬物送達医療機器であって、前記複数のナノキャリアのうちの少なくとも1つのナノキャリアは、前記生物学的薬剤によって取り囲まれた薬物および少なくとも1つの高分子をさらに含む薬物送達医療機器。
- 請求項5に記載の薬物送達医療機器であって、前記少なくとも1つの高分子は、ポリ(l−ラクチド)、ラセミ体ポリラクチド、ポリ(l−ラクチド−co−グリコリド)、ラセミ体ポリ(l−ラクチド−co−グリコリド)、ポリ(l−ラクチド−co−カプロラクトン ポリ(d、l−ラクチド−co−カプロラクトン)、ポリ(l−ラクチド−co−トリメチレンカーボネイト)、およびポリ(d、l−ラクチド−co−トリメチレンカーボネイト)の少なくとも1つを含む群より選択され、前記少なくとも1つの高分子は、前記薬物および生物学的薬剤の少なくとも1つと共有結合し、前記親水性表面上に分布される前記薬物の濃度は、0.1μg/mm2〜約8.0μg/mm2の範囲である薬物送達医療機器。
- 請求項1に記載の薬物送達医療機器であって、少なくとも1つの前記生物学的薬剤は、薬物キャリア、添加物、血液成分、血液由来の添加物、リン脂質、固体脂質ナノ粒子、類脂質、ビタミン、および糖分子を含む群より選択される薬物送達医療機器。
- 請求項1に記載の薬物送達医療機器であって、前記生物学的薬剤は、ステロイド、ビタミン、エストラジオール、エステル型脂肪酸、非エステル型脂肪酸、グルコース、イノシトール、L−乳酸塩、リポタンパク質、炭水化物、リン酸三カルシウム、沈殿リン酸カルシウム、第三リン酸カルシウム、ヒト、卵子、および大豆の少なくとも1つに由来する物質、Phospholipon(登録商標) 80H、phospholipon(登録商標) 90H、Lipoids S75、Lipoids E80、Intralipid(登録商標) 20、Lipoid EPC、Lipoids E75、卵子から得られる脂質、大豆から得られる脂質、ホスファチジルコリン、ホスファチジルグリセロール、ホスファチジルイノシトール、ホスファチジルセリン、ホスファチジン酸、カルジオリピン、およびホスファチジルエタノールアミンを含む群より選択される薬物送達医療機器。
- 請求項1に記載の薬物送達医療機器であって、前記薬物は、抗増殖剤、抗炎症剤、抗腫瘍剤、抗血液凝固剤、抗フィブリン剤、抗血栓薬、抗有糸分裂薬、抗生物質、抗アレルギー薬、抗酸化剤、少なくとも1つのフラボノイド、エストロゲン、プロテアーゼ阻害剤、抗体、免疫抑制剤、細胞増殖抑制剤、細胞毒性薬、カルシウムチャネル遮断薬、ホスホジエステラーゼ阻害剤、プロスタグランジン阻害剤、栄養補助食品、ビタミン、抗血小板凝集剤、および遺伝子組み換え上皮細胞を含む群より選択され、前記少なくとも1つのフラボノイドは、ナリゲニン、ナリンギン、エリオジクチオール、ヘスペレチン、ヘスペリジン(エスペリジン)、ケンフェロール、ケルセチン、ルチン、シアニドール、メシアドノール(meciadonol)、カテキン、没食子酸エピガロカテキン、タキシフォリン(ジヒドロクエルセチン)、ゲニステイン、ゲニスチン、ダイゼイン、ビオカニン、グリシテイン、クリシン、ジオスミン、ルエトリン(luetolin)、アピゲニン、タンゲリチン、およびノビレチンの少なくとも1つを含む群より選択される薬物送達医療機器。
- 請求項1に記載の薬物送達医療機器であって、前記薬物は、シロリムス、パクリタキセル、タクロリムス、クロベタゾール、デキサメタゾン、ゲニステイン、ヘパリン、β−エストラジオール、ラパマイシン、エベロリムス、エチルラパマイシン、ゾタロリムス、ABT−578、バイオリムスA9、ドセタキセル、メトトレキサート、アザチオプリン、ビンクリスチン、ビンブラスチン、フルオロウラシル、塩酸ドキソルビシン、マイトマイシン、ヘパリンナトリウム、低分子量ヘパリン、ヘパリン類似物質、ヒルジン、アルガトロバン、ホルスコリン、バピプロスト、プロスタサイクリン、プロスタサイクリン類似体、デキストラン、D−phe−pro−arg−クロロメチルケトン、ジピリダモール、糖タンパク質IIb/IIIa、組換体ヒルジン、ビバリルジン、ニフェジピン、コルヒチン、ロバスタチン、ニトロプルシド、スラミン、セロトニン阻害薬、ステロイド、チオールプロテアーゼ阻害剤、トリアゾロピリミジン、一酸化窒素、一酸化窒素供与体、スーパーオキシドジスムターゼ、スーパーオキシドジスムターゼ模倣剤、エストラジオール、アスピリン、アンギオペプチン、カプトプリル、シラザプリル、リシノプリル、ペミロラストカリウム、α−インターフェロン、および生物活性RGDを含む群より選択される薬物送達医療機器。
- 請求項1に記載の薬物送達医療機器であって、前記薬物は、シロリムスおよびパクリタキセルを含む群より選択される薬物送達医療機器。
- 請求項1に記載の薬物送達医療機器であって、前記身体内腔は血管を含み、前記血管は、冠動脈、末梢動脈、頸動脈、腎動脈、腸骨動脈、膝下の動脈、および静脈の1つである薬物送達医療機器。
- 請求項1に記載の薬物送達医療機器であって、前記薬物送達医療機器は、医学的状態を治療するために使用され前記医学的状態は、狭窄、再狭窄、動脈閉塞、動脈内血栓、急性心筋梗塞、および動脈病変を含む群より選択される薬物送達医療機器。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1337MU2009 | 2009-06-02 | ||
IN1337/MUM/2009 | 2009-06-02 | ||
PCT/IN2010/000349 WO2010140163A2 (en) | 2009-06-02 | 2010-05-21 | Rejuvenating coronary artery by improving blood flow with the help of insertion of nano-balls (encapsulated nanoparticles) containing therapeutic agents by non implantable device for tissues and thereby providing in tissue release to address the required cell cycle |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012528660A JP2012528660A (ja) | 2012-11-15 |
JP5741576B2 true JP5741576B2 (ja) | 2015-07-01 |
Family
ID=43298260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012513739A Active JP5741576B2 (ja) | 2009-06-02 | 2010-05-21 | 薬物送達医療機器 |
Country Status (15)
Country | Link |
---|---|
US (1) | US8801662B2 (ja) |
EP (1) | EP2437844B1 (ja) |
JP (1) | JP5741576B2 (ja) |
CN (1) | CN102458555B (ja) |
AU (1) | AU2010255329B2 (ja) |
CA (1) | CA2764110A1 (ja) |
DK (1) | DK2437844T3 (ja) |
ES (1) | ES2676537T3 (ja) |
IL (1) | IL216450A (ja) |
NZ (1) | NZ597307A (ja) |
PL (1) | PL2437844T3 (ja) |
RU (1) | RU2573045C2 (ja) |
TR (1) | TR201810457T4 (ja) |
WO (1) | WO2010140163A2 (ja) |
ZA (1) | ZA201109416B (ja) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7252834B2 (en) | 2005-04-25 | 2007-08-07 | Clemson University Research Foundation (Curf) | Elastin stabilization of connective tissue |
WO2010137037A2 (en) * | 2009-05-29 | 2010-12-02 | Envision Scientific Private Limited | Re-establishment of blood flow in blocked human arteries by transferring nano-encapsulated drug through medical devices, designed for the same and releasing the nano- encapsulated drug in human artery with body ph |
TR201906372T4 (tr) * | 2010-01-18 | 2019-05-21 | Concept Medical Res Private Limited | Nano taşıyıcılara ait formülasyonlar ve bunların hazırlanmasına ilişkin yöntemler. |
CA2787002A1 (en) * | 2010-01-25 | 2011-07-28 | Concept Medical Research Private Limited | A method and an insertable medical device for delivering one or more pro-healing agents to a target site within a blood vessel post-deployment of a stent |
US8911468B2 (en) | 2011-01-31 | 2014-12-16 | Vatrix Medical, Inc. | Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection |
JP2014516695A (ja) | 2011-05-18 | 2014-07-17 | バトリックス・メディカル・インコーポレイテッド | 血管安定化用被覆バルーン |
US9358042B2 (en) | 2013-03-13 | 2016-06-07 | The Spectranetics Corporation | Expandable member for perforation occlusion |
US11406742B2 (en) | 2014-07-18 | 2022-08-09 | M.A. Med Alliance SA | Coating for intraluminal expandable catheter providing contact transfer of drug micro-reservoirs |
EP3247447B1 (en) * | 2015-01-22 | 2023-08-23 | Intersect ENT, Inc. | Drug-coated expandable device for treating nasal, otic, or throat conditions |
US10449336B2 (en) | 2015-08-11 | 2019-10-22 | The Spectranetics Corporation | Temporary occlusions balloon devices and methods for preventing blood flow through a vascular perforation |
US10499892B2 (en) | 2015-08-11 | 2019-12-10 | The Spectranetics Corporation | Temporary occlusion balloon devices and methods for preventing blood flow through a vascular perforation |
CN105327353B (zh) * | 2015-12-03 | 2019-06-18 | 中国人民解放军第三军医大学 | 一种模拟超氧化物歧化酶/过氧化氢酶的纳米药物、制备方法及其应用 |
WO2018114989A1 (en) * | 2016-12-22 | 2018-06-28 | Biotronik Ag | Intratumoral drug delivery materials and methods for treating breast cancer |
US11672959B2 (en) | 2019-01-18 | 2023-06-13 | Intersect Ent, Inc. | Expandable member systems and methods for drug delivery |
JP2022536885A (ja) | 2019-04-08 | 2022-08-22 | パテル、ウダヤン | バイパス通路を備えたカテーテル上の膨張可能バルーン |
CN110327465B (zh) * | 2019-07-06 | 2021-12-14 | 五邑大学 | 一种复方抗前列腺癌药物 |
KR102262342B1 (ko) * | 2019-08-27 | 2021-06-07 | 한양대학교 산학협력단 | 약물전달장치 및 이를 이용한 약물전달방법 |
CN111588914A (zh) * | 2019-12-31 | 2020-08-28 | 辽宁垠艺生物科技股份有限公司 | 介入或植入医疗器械的药物涂层及其制备方法 |
CN111671982A (zh) * | 2020-05-08 | 2020-09-18 | 北京永益润成科技有限公司 | 一种药物涂层组合物及其制备方法 |
CN112402702A (zh) * | 2020-12-04 | 2021-02-26 | 上海康德莱医疗器械股份有限公司 | 一种药物涂层组合物以及一种药物涂层球囊 |
WO2022217398A1 (en) * | 2021-04-12 | 2022-10-20 | Orbusneich Medical (Shenzhen) Co., Ltd | Expandable balloon catheter |
CN115006605A (zh) * | 2022-07-20 | 2022-09-06 | 苏州中天医疗器械科技有限公司 | 一种药物涂层球囊及其制备方法和应用 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5674192A (en) * | 1990-12-28 | 1997-10-07 | Boston Scientific Corporation | Drug delivery |
US5893840A (en) * | 1991-01-04 | 1999-04-13 | Medtronic, Inc. | Releasable microcapsules on balloon catheters |
US5102402A (en) * | 1991-01-04 | 1992-04-07 | Medtronic, Inc. | Releasable coatings on balloon catheters |
US5652225A (en) * | 1994-10-04 | 1997-07-29 | St. Elizabeth's Medical Center Of Boston, Inc. | Methods and products for nucleic acid delivery |
US5603991A (en) * | 1995-09-29 | 1997-02-18 | Target Therapeutics, Inc. | Method for coating catheter lumens |
US6132765A (en) * | 1996-04-12 | 2000-10-17 | Uroteq Inc. | Drug delivery via therapeutic hydrogels |
US6419692B1 (en) | 1999-02-03 | 2002-07-16 | Scimed Life Systems, Inc. | Surface protection method for stents and balloon catheters for drug delivery |
DE50210591D1 (de) * | 2001-02-16 | 2007-09-13 | Abbott Lab Vascular Entpr Ltd | Implantate mit fk506 zur restenosebehandlung und -prophylaxe |
US20030064965A1 (en) * | 2001-10-02 | 2003-04-03 | Jacob Richter | Method of delivering drugs to a tissue using drug-coated medical devices |
US20030135195A1 (en) * | 2002-01-16 | 2003-07-17 | Oscar Jimenez | Highly lubricious hydrophilic coating utilizing dendrimers |
DE10244847A1 (de) * | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
US7060051B2 (en) * | 2002-09-24 | 2006-06-13 | Scimed Life Systems, Inc. | Multi-balloon catheter with hydrogel coating |
US7048714B2 (en) * | 2002-10-30 | 2006-05-23 | Biorest Ltd. | Drug eluting medical device with an expandable portion for drug release |
US20060047261A1 (en) * | 2004-06-28 | 2006-03-02 | Shailendra Joshi | Intra-arterial catheter for drug delivery |
US7972616B2 (en) * | 2003-04-17 | 2011-07-05 | Nanosys, Inc. | Medical device applications of nanostructured surfaces |
JP2004357872A (ja) * | 2003-06-03 | 2004-12-24 | Terumo Corp | 体腔内拡張用カテーテル |
US8119153B2 (en) * | 2004-08-26 | 2012-02-21 | Boston Scientific Scimed, Inc. | Stents with drug eluting coatings |
US7491188B2 (en) * | 2004-10-12 | 2009-02-17 | Boston Scientific Scimed, Inc. | Reinforced and drug-eluting balloon catheters and methods for making same |
CN101309706A (zh) * | 2005-11-16 | 2008-11-19 | 学校法人东海大学 | 药剂释放控制组合物及药剂释放性医疗器具 |
EP1832301A3 (en) * | 2006-03-08 | 2007-12-05 | Sahajanand Medical Technologies PVT. ltd | Coatings for implantable medical devices |
WO2008063157A2 (en) * | 2006-10-25 | 2008-05-29 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | A nanoparticle-based anticoagulant |
US20080175887A1 (en) * | 2006-11-20 | 2008-07-24 | Lixiao Wang | Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs |
DE102007036685A1 (de) * | 2007-08-03 | 2009-02-05 | Innora Gmbh | Verbesserte arzneimittelbeschichtete Medizinprodukte deren Herstellung und Verwendung |
CA2702183A1 (en) * | 2007-10-10 | 2009-04-16 | Miv Therapeutics Inc. | Lipid coatings for implantable medical devices |
EP2689789B1 (en) * | 2008-03-28 | 2019-03-13 | SurModics, Inc. | Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery |
US9126025B2 (en) * | 2008-05-01 | 2015-09-08 | Bayer Intellectual Property Gmbh | Method of coating a folded catheter balloon |
WO2010137037A2 (en) * | 2009-05-29 | 2010-12-02 | Envision Scientific Private Limited | Re-establishment of blood flow in blocked human arteries by transferring nano-encapsulated drug through medical devices, designed for the same and releasing the nano- encapsulated drug in human artery with body ph |
-
2010
- 2010-05-21 ES ES10783060.6T patent/ES2676537T3/es active Active
- 2010-05-21 CN CN201080029131.2A patent/CN102458555B/zh active Active
- 2010-05-21 WO PCT/IN2010/000349 patent/WO2010140163A2/en active Application Filing
- 2010-05-21 JP JP2012513739A patent/JP5741576B2/ja active Active
- 2010-05-21 TR TR2018/10457T patent/TR201810457T4/tr unknown
- 2010-05-21 US US12/920,812 patent/US8801662B2/en active Active
- 2010-05-21 EP EP10783060.6A patent/EP2437844B1/en active Active
- 2010-05-21 DK DK10783060.6T patent/DK2437844T3/en active
- 2010-05-21 AU AU2010255329A patent/AU2010255329B2/en active Active
- 2010-05-21 NZ NZ597307A patent/NZ597307A/en unknown
- 2010-05-21 CA CA2764110A patent/CA2764110A1/en not_active Abandoned
- 2010-05-21 RU RU2011153742/14A patent/RU2573045C2/ru active
- 2010-05-21 PL PL10783060T patent/PL2437844T3/pl unknown
-
2011
- 2011-11-17 IL IL216450A patent/IL216450A/en active IP Right Grant
- 2011-12-21 ZA ZA2011/09416A patent/ZA201109416B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA201109416B (en) | 2012-08-29 |
AU2010255329B2 (en) | 2016-02-25 |
EP2437844A2 (en) | 2012-04-11 |
RU2573045C2 (ru) | 2016-01-20 |
IL216450A (en) | 2015-08-31 |
ES2676537T3 (es) | 2018-07-20 |
US20120065584A1 (en) | 2012-03-15 |
IL216450A0 (en) | 2012-01-31 |
JP2012528660A (ja) | 2012-11-15 |
WO2010140163A2 (en) | 2010-12-09 |
CN102458555A (zh) | 2012-05-16 |
WO2010140163A3 (en) | 2011-01-27 |
TR201810457T4 (tr) | 2018-08-27 |
PL2437844T3 (pl) | 2018-10-31 |
NZ597307A (en) | 2014-04-30 |
CN102458555B (zh) | 2015-12-16 |
RU2011153742A (ru) | 2013-07-20 |
EP2437844B1 (en) | 2018-05-02 |
EP2437844A4 (en) | 2013-10-16 |
DK2437844T3 (en) | 2018-07-30 |
AU2010255329A1 (en) | 2011-12-22 |
CA2764110A1 (en) | 2010-12-09 |
US8801662B2 (en) | 2014-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5741576B2 (ja) | 薬物送達医療機器 | |
US9162014B2 (en) | Method and an insertable medical device for delivering one or more pro-healing agents to a target site within a blood vessel post-deployment of a stent | |
US9259518B2 (en) | Re-establishment of blood flow in blocked human arteries by transferring nano-encapsulated drug through medical devices, designed for the same and releasing the nano-encapsulated drug in human artery with body ph | |
US8585642B2 (en) | Method and a balloon catheter assembly for treating bifurcation lesions | |
US20150079160A1 (en) | Non-implantable medical device coated with nano-carriers for delivering one or more drugs to a body site | |
US9034363B2 (en) | Drug-eluting insertable medical device for treating acute myocardial infarction, thrombus containing lesions and saphenous-vein graft lesions | |
US9168360B2 (en) | Method and a balloon catheter assembly for treating bifurcation lesions | |
US20150202062A1 (en) | Nano-carrier embedded surface for insertable medical devices | |
PIIRURCATION | 12, Patent Application Publication o Pub. No.: US 2012/0283635 A1 | |
NANO | RE-ESTABLISHMENT OF BLOOD FLow IN BLockED HUMAN ARTERIEs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130521 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130612 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140318 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20140320 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140617 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140624 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140718 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140813 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140815 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140905 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140918 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150317 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150413 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5741576 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |